APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Transforming Growth Factor-β

Compare research editions
View pricing & licenses

Selected research

Industry Research

Recombinant Human Transforming Growth Factor-β Industry Research Report 2026

26 December 2025149 pages

Choose your research edition.

Industry ResearchRecombinant Human Transforming Growth Factor-β Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Transforming Growth Factor-β Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Recombinant Human Transforming Growth Factor-β Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Transforming Growth Factor-β Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Transforming Growth Factor-β Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Recombinant Human Transforming Growth Factor-β market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Recombinant Human Transforming Growth Factor-β is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Transforming Growth Factor-β is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Recombinant Human Transforming Growth Factor-β include Abcam, ACROBiosystems, Atlantis Bioscience, Bio-Techne, Cell Guidance Systems, Cell Signaling Technology, Croyez Bioscience, FUJIFILM Irvine Scientific and MedChemExpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Recombinant Human Transforming Growth Factor-β market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Recombinant Human Transforming Growth Factor-β Market by Company

Abcam

ACROBiosystems

Atlantis Bioscience

Bio-Techne

Cell Guidance Systems

Cell Signaling Technology

Croyez Bioscience

FUJIFILM Irvine Scientific

MedChemExpress

Miltenyi Biotec

Proteintech

Qkine

Sigma-Aldrich

Beijing T&L Biotechnology

Beijing Sino Biological

Dalian Meilun Biotechnology

Cellverse

Nanjing Okay Biotechnology

Thermo Fisher

Shanghai DiLab Biotechnology

Shanghai Zhong Qiao Xin Zhou Biotechnology

Suzhou Novoprotein Scientific

Abbkine Scientific

EIAAB SCIENCE

Yeasen Biotechnology (Shanghai)

Recombinant Human Transforming Growth Factor-β Segment by Type

TGF-β3

TGF-β2

TGF-β1

Recombinant Human Transforming Growth Factor-β Segment by Application

Hospital

Research Institute

Others

Recombinant Human Transforming Growth Factor-β Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Transforming Growth Factor-β market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Transforming Growth Factor-β and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Transforming Growth Factor-β.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Recombinant Human Transforming Growth Factor-β manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Recombinant Human Transforming Growth Factor-β by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Recombinant Human Transforming Growth Factor-β in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Recombinant Human Transforming Growth Factor-β Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021-2026) Table 8. Global Recombinant Human Transforming Growth Factor-β Revenue of Manufacturers (2021-2026) Table 9. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Recombinant Human Transforming Growth Factor-β Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Type & Application Table 14. Global Recombinant Human Transforming Growth Factor-β Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Recombinant Human Transforming Growth Factor-β by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abcam Company Information Table 19. Abcam Business Overview Table 20. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio Table 22. Abcam Recent Developments Table 23. ACROBiosystems Company Information Table 24. ACROBiosystems Business Overview Table 25. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 27. ACROBiosystems Recent Developments Table 28. Atlantis Bioscience Company Information Table 29. Atlantis Bioscience Business Overview Table 30. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 32. Atlantis Bioscience Recent Developments Table 33. Bio-Techne Company Information Table 34. Bio-Techne Business Overview Table 35. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio Table 37. Bio-Techne Recent Developments Table 38. Cell Guidance Systems Company Information Table 39. Cell Guidance Systems Business Overview Table 40. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 42. Cell Guidance Systems Recent Developments Table 43. Cell Signaling Technology Company Information Table 44. Cell Signaling Technology Business Overview Table 45. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 47. Cell Signaling Technology Recent Developments Table 48. Croyez Bioscience Company Information Table 49. Croyez Bioscience Business Overview Table 50. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 52. Croyez Bioscience Recent Developments Table 53. FUJIFILM Irvine Scientific Company Information Table 54. FUJIFILM Irvine Scientific Business Overview Table 55. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 57. FUJIFILM Irvine Scientific Recent Developments Table 58. MedChemExpress Company Information Table 59. MedChemExpress Business Overview Table 60. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio Table 62. MedChemExpress Recent Developments Table 63. Miltenyi Biotec Company Information Table 64. Miltenyi Biotec Business Overview Table 65. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio Table 67. Miltenyi Biotec Recent Developments Table 68. Proteintech Company Information Table 69. Proteintech Business Overview Table 70. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio Table 72. Proteintech Recent Developments Table 73. Qkine Company Information Table 74. Qkine Business Overview Table 75. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio Table 77. Qkine Recent Developments Table 78. Sigma-Aldrich Company Information Table 79. Sigma-Aldrich Business Overview Table 80. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio Table 82. Sigma-Aldrich Recent Developments Table 83. Beijing T&L Biotechnology Company Information Table 84. Beijing T&L Biotechnology Business Overview Table 85. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 87. Beijing T&L Biotechnology Recent Developments Table 88. Beijing Sino Biological Company Information Table 89. Beijing Sino Biological Business Overview Table 90. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio Table 92. Beijing Sino Biological Recent Developments Table 93. Dalian Meilun Biotechnology Company Information Table 94. Dalian Meilun Biotechnology Business Overview Table 95. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 97. Dalian Meilun Biotechnology Recent Developments Table 98. Cellverse Company Information Table 99. Cellverse Business Overview Table 100. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio Table 102. Cellverse Recent Developments Table 103. Nanjing Okay Biotechnology Company Information Table 104. Nanjing Okay Biotechnology Business Overview Table 105. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 107. Nanjing Okay Biotechnology Recent Developments Table 108. Thermo Fisher Company Information Table 109. Thermo Fisher Business Overview Table 110. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio Table 112. Thermo Fisher Recent Developments Table 113. Shanghai DiLab Biotechnology Company Information Table 114. Shanghai DiLab Biotechnology Business Overview Table 115. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 117. Shanghai DiLab Biotechnology Recent Developments Table 118. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 119. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 120. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 122. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments Table 123. Suzhou Novoprotein Scientific Company Information Table 124. Suzhou Novoprotein Scientific Business Overview Table 125. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 127. Suzhou Novoprotein Scientific Recent Developments Table 128. Abbkine Scientific Company Information Table 129. Abbkine Scientific Business Overview Table 130. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 132. Abbkine Scientific Recent Developments Table 133. EIAAB SCIENCE Company Information Table 134. EIAAB SCIENCE Business Overview Table 135. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio Table 137. EIAAB SCIENCE Recent Developments Table 138. Yeasen Biotechnology (Shanghai) Company Information Table 139. Yeasen Biotechnology (Shanghai) Business Overview Table 140. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio Table 142. Yeasen Biotechnology (Shanghai) Recent Developments Table 143. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 144. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026) & (K Units) Table 145. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021-2026) Table 146. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032) & (K Units) Table 147. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2027-2032) Table 148. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2021-2026) & (US$ Million) Table 149. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021-2026) Table 150. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2027-2032) & (US$ Million) Table 151. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2027-2032) Table 152. North America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 154. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 155. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2026) & (US$ Million) Table 156. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (2027-2032) & (US$ Million) Table 157. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 159. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 160. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2026) & (US$ Million) Table 161. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (2027-2032) & (US$ Million) Table 162. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 164. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 165. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2026) & (US$ Million) Table 166. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Country (2027-2032) & (US$ Million) Table 167. South America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. South America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 169. South America Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 170. South America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2026) & (US$ Million) Table 171. South America Recombinant Human Transforming Growth Factor-β Revenue by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (2027-2032) & (US$ Million) Table 177. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 178. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 179. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2026) Table 180. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2027-2032) Table 181. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 182. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 183. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2026) Table 184. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2027-2032) Table 185. Global Recombinant Human Transforming Growth Factor-β Price by Type (2021-2026) & (US$/Unit) Table 186. Global Recombinant Human Transforming Growth Factor-β Price by Type (2027-2032) & (US$/Unit) Table 187. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 188. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 189. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2026) Table 190. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2027-2032) Table 191. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 192. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 193. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2026) Table 194. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2027-2032) Table 195. Global Recombinant Human Transforming Growth Factor-β Price by Application (2021-2026) & (US$/Unit) Table 196. Global Recombinant Human Transforming Growth Factor-β Price by Application (2027-2032) & (US$/Unit) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Recombinant Human Transforming Growth Factor-β Distributors List Table 200. Recombinant Human Transforming Growth Factor-β Customers List Table 201. Recombinant Human Transforming Growth Factor-β Industry Trends Table 202. Recombinant Human Transforming Growth Factor-β Industry Drivers Table 203. Recombinant Human Transforming Growth Factor-β Industry Restraints Table 204. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Recombinant Human Transforming Growth Factor-β Product Image Figure 5. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Recombinant Human Transforming Growth Factor-β Market Size (2021-2032) & (US$ Million) Figure 7. Global Recombinant Human Transforming Growth Factor-β Sales (2021-2032) & (K Units) Figure 8. Global Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) & (2021-2032) Figure 9. TGF-β3 Product Image Figure 10. TGF-β2 Product Image Figure 11. TGF-β1 Product Image Figure 12. Hospital Product Image Figure 13. Research Institute Product Image Figure 14. Others Product Image Figure 15. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Recombinant Human Transforming Growth Factor-β Sales by Region in 2025 Figure 21. Global Recombinant Human Transforming Growth Factor-β Revenue by Region in 2025 Figure 22. North America Recombinant Human Transforming Growth Factor-β Market Size by Country in 2025 Figure 23. North America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 24. North America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021-2032) Figure 25. United States Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Recombinant Human Transforming Growth Factor-β Market Size by Country in 2025 Figure 29. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 30. Europe Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021-2032) Figure 31. Germany Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Recombinant Human Transforming Growth Factor-β Market Size by Country in 2025 Figure 42. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021-2032) Figure 44. China Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Recombinant Human Transforming Growth Factor-β Market Size by Country in 2025 Figure 53. South America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 54. South America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021-2032) Figure 55. Brazil Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country in 2025 Figure 60. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021-2032) Figure 62. Egypt Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2032) Figure 68. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2032) Figure 69. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021-2032) Figure 70. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2032) Figure 71. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2032) Figure 72. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021-2032) Figure 73. Recombinant Human Transforming Growth Factor-β Value Chain Figure 74. Recombinant Human Transforming Growth Factor-β Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges

Scope & coverage.

Types
  • TGF-β3
  • TGF-β2
  • TGF-β1
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • Abcam
  • ACROBiosystems
  • Atlantis Bioscience
  • Bio-Techne
  • Cell Guidance Systems
  • Cell Signaling Technology
  • Croyez Bioscience
  • FUJIFILM Irvine Scientific
  • MedChemExpress
  • Miltenyi Biotec
  • Proteintech
  • Qkine
  • Sigma-Aldrich
  • Beijing T&L Biotechnology
  • Beijing Sino Biological
  • Dalian Meilun Biotechnology
  • Cellverse
  • Nanjing Okay Biotechnology
  • Thermo Fisher
  • Shanghai DiLab Biotechnology
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Suzhou Novoprotein Scientific
  • Abbkine Scientific
  • EIAAB SCIENCE
  • Yeasen Biotechnology (Shanghai)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Recombinant Human Transforming Growth Factor-β Market Size (2021-2032)
  4. 2.2.2 Global Recombinant Human Transforming Growth Factor-β Sales (2021-2032)
  5. 2.2.3 Global Recombinant Human Transforming Growth Factor-β Market Average Price (2021-2032)
  6. 2.3 Recombinant Human Transforming Growth Factor-β by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 TGF-β3
  9. 2.3.3 TGF-β2
  10. 2.3.4 TGF-β1
  11. 2.4 Recombinant Human Transforming Growth Factor-β by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Research Institute
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Recombinant Human Transforming Growth Factor-β Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Human Transforming Growth Factor-β Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Human Transforming Growth Factor-β Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Recombinant Human Transforming Growth Factor-β Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Type & Application
  8. 3.8 Global Manufacturers of Recombinant Human Transforming Growth Factor-β, Established Date
  9. 3.9 Global Recombinant Human Transforming Growth Factor-β Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abcam
  2. 4.1.1 Abcam Company Information
  3. 4.1.2 Abcam Business Overview
  4. 4.1.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
  6. 4.1.5 Abcam Recent Developments
  7. 4.2 ACROBiosystems
  8. 4.2.1 ACROBiosystems Company Information
  9. 4.2.2 ACROBiosystems Business Overview
  10. 4.2.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
  12. 4.2.5 ACROBiosystems Recent Developments
  13. 4.3 Atlantis Bioscience
  14. 4.3.1 Atlantis Bioscience Company Information
  15. 4.3.2 Atlantis Bioscience Business Overview
  16. 4.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  18. 4.3.5 Atlantis Bioscience Recent Developments
  19. 4.4 Bio-Techne
  20. 4.4.1 Bio-Techne Company Information
  21. 4.4.2 Bio-Techne Business Overview
  22. 4.4.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
  24. 4.4.5 Bio-Techne Recent Developments
  25. 4.5 Cell Guidance Systems
  26. 4.5.1 Cell Guidance Systems Company Information
  27. 4.5.2 Cell Guidance Systems Business Overview
  28. 4.5.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
  30. 4.5.5 Cell Guidance Systems Recent Developments
  31. 4.6 Cell Signaling Technology
  32. 4.6.1 Cell Signaling Technology Company Information
  33. 4.6.2 Cell Signaling Technology Business Overview
  34. 4.6.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
  36. 4.6.5 Cell Signaling Technology Recent Developments
  37. 4.7 Croyez Bioscience
  38. 4.7.1 Croyez Bioscience Company Information
  39. 4.7.2 Croyez Bioscience Business Overview
  40. 4.7.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  42. 4.7.5 Croyez Bioscience Recent Developments
  43. 4.8 FUJIFILM Irvine Scientific
  44. 4.8.1 FUJIFILM Irvine Scientific Company Information
  45. 4.8.2 FUJIFILM Irvine Scientific Business Overview
  46. 4.8.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  48. 4.8.5 FUJIFILM Irvine Scientific Recent Developments
  49. 4.9 MedChemExpress
  50. 4.9.1 MedChemExpress Company Information
  51. 4.9.2 MedChemExpress Business Overview
  52. 4.9.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
  54. 4.9.5 MedChemExpress Recent Developments
  55. 4.10 Miltenyi Biotec
  56. 4.10.1 Miltenyi Biotec Company Information
  57. 4.10.2 Miltenyi Biotec Business Overview
  58. 4.10.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
  60. 4.10.5 Miltenyi Biotec Recent Developments
  61. 4.11 Proteintech
  62. 4.11.1 Proteintech Company Information
  63. 4.11.2 Proteintech Business Overview
  64. 4.11.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
  66. 4.11.5 Proteintech Recent Developments
  67. 4.12 Qkine
  68. 4.12.1 Qkine Company Information
  69. 4.12.2 Qkine Business Overview
  70. 4.12.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
  72. 4.12.5 Qkine Recent Developments
  73. 4.13 Sigma-Aldrich
  74. 4.13.1 Sigma-Aldrich Company Information
  75. 4.13.2 Sigma-Aldrich Business Overview
  76. 4.13.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
  78. 4.13.5 Sigma-Aldrich Recent Developments
  79. 4.14 Beijing T&L Biotechnology
  80. 4.14.1 Beijing T&L Biotechnology Company Information
  81. 4.14.2 Beijing T&L Biotechnology Business Overview
  82. 4.14.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  84. 4.14.5 Beijing T&L Biotechnology Recent Developments
  85. 4.15 Beijing Sino Biological
  86. 4.15.1 Beijing Sino Biological Company Information
  87. 4.15.2 Beijing Sino Biological Business Overview
  88. 4.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
  90. 4.15.5 Beijing Sino Biological Recent Developments
  91. 4.16 Dalian Meilun Biotechnology
  92. 4.16.1 Dalian Meilun Biotechnology Company Information
  93. 4.16.2 Dalian Meilun Biotechnology Business Overview
  94. 4.16.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  96. 4.16.5 Dalian Meilun Biotechnology Recent Developments
  97. 4.17 Cellverse
  98. 4.17.1 Cellverse Company Information
  99. 4.17.2 Cellverse Business Overview
  100. 4.17.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
  102. 4.17.5 Cellverse Recent Developments
  103. 4.18 Nanjing Okay Biotechnology
  104. 4.18.1 Nanjing Okay Biotechnology Company Information
  105. 4.18.2 Nanjing Okay Biotechnology Business Overview
  106. 4.18.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  108. 4.18.5 Nanjing Okay Biotechnology Recent Developments
  109. 4.19 Thermo Fisher
  110. 4.19.1 Thermo Fisher Company Information
  111. 4.19.2 Thermo Fisher Business Overview
  112. 4.19.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
  114. 4.19.5 Thermo Fisher Recent Developments
  115. 4.20 Shanghai DiLab Biotechnology
  116. 4.20.1 Shanghai DiLab Biotechnology Company Information
  117. 4.20.2 Shanghai DiLab Biotechnology Business Overview
  118. 4.20.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  120. 4.20.5 Shanghai DiLab Biotechnology Recent Developments
  121. 4.21 Shanghai Zhong Qiao Xin Zhou Biotechnology
  122. 4.21.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  123. 4.21.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  124. 4.21.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  126. 4.21.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  127. 4.22 Suzhou Novoprotein Scientific
  128. 4.22.1 Suzhou Novoprotein Scientific Company Information
  129. 4.22.2 Suzhou Novoprotein Scientific Business Overview
  130. 4.22.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  132. 4.22.5 Suzhou Novoprotein Scientific Recent Developments
  133. 4.23 Abbkine Scientific
  134. 4.23.1 Abbkine Scientific Company Information
  135. 4.23.2 Abbkine Scientific Business Overview
  136. 4.23.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  138. 4.23.5 Abbkine Scientific Recent Developments
  139. 4.24 EIAAB SCIENCE
  140. 4.24.1 EIAAB SCIENCE Company Information
  141. 4.24.2 EIAAB SCIENCE Business Overview
  142. 4.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
  144. 4.24.5 EIAAB SCIENCE Recent Developments
  145. 4.25 Yeasen Biotechnology (Shanghai)
  146. 4.25.1 Yeasen Biotechnology (Shanghai) Company Information
  147. 4.25.2 Yeasen Biotechnology (Shanghai) Business Overview
  148. 4.25.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
  150. 4.25.5 Yeasen Biotechnology (Shanghai) Recent Developments
5 Global Recombinant Human Transforming Growth Factor-β Market Scenario by Region
  1. 5.1 Global Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021-2032
  3. 5.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021-2026
  4. 5.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2027-2032
  5. 5.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021-2032
  6. 5.3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021-2026
  7. 5.3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2027-2032
  8. 5.4 North America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
  9. 5.4.1 North America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  11. 5.4.3 North America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
  16. 5.5.1 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  18. 5.5.3 Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
  41. 5.7.1 South America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  43. 5.7.3 South America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  2. 6.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2032)
  4. 6.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  5. 6.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Recombinant Human Transforming Growth Factor-β Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  2. 7.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2032)
  4. 7.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  5. 7.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Recombinant Human Transforming Growth Factor-β Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Recombinant Human Transforming Growth Factor-β Value Chain Analysis
  2. 8.1.1 Recombinant Human Transforming Growth Factor-β Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Recombinant Human Transforming Growth Factor-β Production Mode & Process
  5. 8.2 Recombinant Human Transforming Growth Factor-β Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Recombinant Human Transforming Growth Factor-β Distributors
  8. 8.2.3 Recombinant Human Transforming Growth Factor-β Customers
9 Global Recombinant Human Transforming Growth Factor-β Analyzing Market Dynamics
  1. 9.1 Recombinant Human Transforming Growth Factor-β Industry Trends
  2. 9.2 Recombinant Human Transforming Growth Factor-β Industry Drivers
  3. 9.3 Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges
  4. 9.4 Recombinant Human Transforming Growth Factor-β Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst